Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-08-22 | Applied Therapeutics, Inc. | Funtleyder Leslie D.
(Chief Financial Officer) |
S | Common Stock | D | 13530 | $5.83 - $5.83 | $78,879 |
| 2024-08-22 | Applied Therapeutics, Inc. | Perfetti Riccardo
(Chief Medical Officer) |
S | Common Stock | D | 22681 | $5.83 - $5.83 | $132,230 |
| 2024-08-12 | Applied Therapeutics, Inc. | Shendelman Shoshana
(President and CEO) |
S | Common Stock | D | 777014 | $5.93 - $6.18 | $4,712,048 |
| 2024-08-05 | Applied Therapeutics, Inc. | Shendelman Shoshana
(President and CEO) |
G | Common Stock | D | 1495772 | $0.00 - $0.00 | $0 |
| 2024-06-06 | Applied Therapeutics, Inc. | Perfetti Riccardo
(Chief Medical Officer) |
S | Common Stock | D | 22003 | $4.32 - $4.32 | $95,052 |
| 2024-06-06 | Applied Therapeutics, Inc. | Funtleyder Leslie D.
(Chief Financial Officer) |
S | Common Stock | D | 16980 | $4.32 - $4.32 | $73,353 |
| 2024-06-06 | Applied Therapeutics, Inc. | Kanter Stacy J.
(Director) |
A | Common Stock | A | 45000 | $0.00 - $0.00 | $0 |
| 2024-06-06 | Applied Therapeutics, Inc. | Lerner Teena
(Director) |
A | Common Stock | A | 45000 | $0.00 - $0.00 | $0 |
| 2024-06-04 | Applied Therapeutics, Inc. | Alexandria Equiti...
(AtLeastTenPercentOwner) |
S | Common Stock | D | 300000 | $4.21 - $4.24 | $1,267,500 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |